President Donald Trump signed an executive order on April 17, 2026 [1], directing the FDA to accelerate its review of psychedelic drugs.
The move signals a shift in federal policy toward substances previously heavily restricted. By easing these regulations, the administration aims to catalyze medical research into treating severe depression and post-traumatic stress disorder (PTSD) [2].
Signed in the Oval Office in Washington, D.C. [3], the order specifically targets psychedelic drugs that have been designated as breakthrough-therapy drugs [2]. This designation is intended to streamline the path from laboratory research to clinical application for patients with treatment-resistant mental health conditions [2].
While some reports suggest the order allows for the immediate use of psychedelics to combat PTSD [4], other accounts clarify that the directive focuses on the research process rather than immediate widespread clinical use [5]. The primary goal remains the acceleration of the FDA review timeline to foster scientific discovery [2].
Reports regarding the impetus for the order vary. Some sources said the administration acted to promote medical research for severe depression [2], while others said President Trump signed the order after receiving a text from podcast host Joe Rogan [4].
The executive order does not remove all legal restrictions on these substances but provides a regulatory pathway for researchers to study their efficacy more efficiently [5]. This approach seeks to balance public safety with the need for innovative psychiatric treatments [2].
“The executive order directs the FDA to accelerate its review of psychedelic drugs designated as breakthrough-therapy drugs.”
This executive order represents a pivot in US drug policy by utilizing 'breakthrough-therapy' designations to bypass traditional regulatory bottlenecks. By prioritizing the review of psychedelics, the government is acknowledging a growing clinical interest in non-traditional psychiatric interventions, potentially shifting the legal landscape for substances that have been strictly prohibited for decades.
